Author: CBD-Intel
Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?
Written by CBD-Intel || 7th May 2021 || Blog |
Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must...
CBD-Intel global alerts database May
Written by CBD-Intel || 7th May 2021 || Alerts roundup |
All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month.This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel...
What are ‘minor cannabinoids’ and what do they do?
Written by CBD-Intel || 5th May 2021 || Charts and infographics |
This chart shows the origins of some select minor cannabinoids that CBD-Intel covered in a recent business briefing. It provides a brief review of some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their...
Legalisation of cannabis looks like being a hot topic in Germany’s federal elections
Written by CBD-Intel || 3rd May 2021 || Regulatory briefing |
With federal elections due in September, Germany’s Free Democratic Party (FDP) has called on the government to draft a law permitting the controlled distribution of cannabis for adult use ...CBD-Intel regulatory news in brief, 24th-30th April
Written by CBD-Intel || 30th April 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from Belgium, Latvia Portugal, UK, US, Argentina, Armenia, Australia and Brazil ...
South Africa’s new national cannabis plan could spark regional change
Written by CBD-Intel || 30th April 2021 || Regulatory briefing |
South Africa releases the National Cannabis Master Plan, which will not only boost and uplift the southern Africa cannabis industry, but will set a regional precedent for the growth of a legal cannabis market in the area ...
What is the state of science behind minor cannabinoids really like?
Written by CBD-Intel || 29th April 2021 || Blog |
Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor...
Opposition parties put forward proposals for legalisation of cannabis in Poland
Written by CBD-Intel || 29th April 2021 || Regulatory briefing |
Poland’s Parliamentary Team for the Legalisation of Marijuana has submitted a package of three draft bills to the speaker of parliament’s lower chamber, following a public consultation on the proposals ...
Minor cannabinoids: what are they, and how could they be of benefit?
Written by CBD-Intel || 28th April 2021 || Business briefing , Resources |
CBD-Intel offers a review of the science behind some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications ...
Podcast: how to nail effective CBD packaging design and target specific markets
Written by CBD-Intel || 27th April 2021 || Podcasts |
CBD-Intel podcast editor Jon Bruford discusses packaging design with Steve Wilkins, senior project manager of Duallok, US manufacturers of child-resistant packaging systems ...CBD-Intel regulatory news in brief, 17th-23rd April
Written by CBD-Intel || 23rd April 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from Germany, Latvia Malta, Netherlands, Poland, Spain, UK, Canada, US, China, Lesotho and...
How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?
Written by CBD-Intel || 22nd April 2021 || Blog |
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in...
CBD and Covid-19 – lab experiments show promise, but don’t hold your breath
Written by CBD-Intel || 21st April 2021 || Business briefing |
Early research into the possibility of CBD having a role to play in the fight against coronavirus infections has shown some initial promise. Any practical application remains a long way off, however ...
A new head honcho for CBD policy – but who will US FDA pick for this vital role?
Written by CBD-Intel || 19th April 2021 || Regulatory briefing |
A new deputy commissioner at the US Food and Drug Administration (FDA) will likely be the single person with the most influence on the path to market for CBD in the US ...
The next big thing – or are investors in psychedelics playing the long game?
Written by CBD-Intel || 19th April 2021 || Business briefing |
While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics ...
Credit union runs into trouble with US agency over too-lax cannabis activities
Written by CBD-Intel || 16th April 2021 || Business briefing |
Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic for financial institutions...CBD-Intel regulatory news in brief, 10th-16th April
Written by CBD-Intel || 16th April 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from France, Italy, Lithuania, Malta, Norway, Poland, Spain, Sweden, Ukraine and the US ...
New Senate request could hold Mexican legalisation back until at least September
Written by CBD-Intel || 15th April 2021 || Regulatory briefing |
Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September ...
Details of China’s proposed ban on CBD in cosmetics still unclear
Written by CBD-Intel || 14th April 2021 || Regulatory briefing |
Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature ...
Is delta-8 THC really the next big thing?
Written by CBD-Intel || 14th April 2021 || Blog |
From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies...
‘A nice buzz in the air’ – CBD shops reopen as UK lockdown lifts
Written by CBD-Intel || 14th April 2021 || Business briefing |
As the national lockdown in the UK lifted on Monday, shoppers were excited to purchase CBD in person ...
‘Cautious’ Idaho is ready at last to become the 50th state to legalise industrial hemp
Written by CBD-Intel || 13th April 2021 || Regulatory briefing |
It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop ...
How cannabis derivatives could help to preserve the miracle of modern medicine
Written by CBD-Intel || 13th April 2021 || Business briefing |
Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics? ...
Could cannabinoids help in the fight against drug-resistant bacteria?
Written by CBD-Intel || 12th April 2021 || Business briefing |
Scientific findings on the antimicrobial properties of cannabis – and in particular cannabinoids – have raised the question of whether they might play a role in combatting antibiotic-resistant bacteria such as MRSA ...CBD-Intel regulatory news in brief, 2nd-9th April
Written by CBD-Intel || 9th April 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from Czech Republic, Belgium, the UK, Mexico and the US ...
A mixed bag: reactions to the USDA’s final hemp rule requirements
Written by CBD-Intel || 9th April 2021 || Regulatory briefing |
States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest ...
Should CBD companies operating in the US be worried about the latest round of FDA enforcement?
Written by CBD-Intel || 8th April 2021 || Blog |
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in...
Italy issues its first licences to grow hemp and extract CBD for medical use
Written by CBD-Intel || 8th April 2021 || Business briefing |
Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes ...
Delta-8 THC – hot new kid on the block, or hemp’s disturbing problem child?
Written by CBD-Intel || 7th April 2021 || Business briefing |
The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost? ...
Germany’s highest court leaves legality of hemp flowers open to interpretation
Written by CBD-Intel || 6th April 2021 || Regulatory briefing |
Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of intoxication ...
CBD firms find more pros than cons in legal recreational cannabis markets
Written by CBD-Intel || 6th April 2021 || Business briefing |
CBD companies see more synergies than threats from the provision of legal cannabis products in states such as Colorado, which has one of the oldest recreational cannabis markets in the US ...CBD-Intel regulatory news in brief, 27th March-1st April
Written by CBD-Intel || 1st April 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from the Cyprus. Czech Republic, the EU, Finland, France, Germany, Iceland, Malta, Switzerland, the US, and Argentina ...
Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?
Written by CBD-Intel || 1st April 2021 || Blog |
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the...
‘Impending disaster’ – UK industry associations at odds over THC limits
Written by CBD-Intel || 31st March 2021 || Business briefing |
The British Hemp Alliance (BHA) has contested the suggestion put forward by the Association for the Cannabinoid Industry (ACI) for allowable THC levels in CBD products, claiming it would only benefit “the big boys” ...
The impact of CBD regulation on global markets; challenges and opportunities
Written by CBD-Intel || 26th March 2021 || Presentations , Resources |
What regulations apply to CBD around the world, how are they set to change, and what impact will the changes have on the cannabidiol sector? A presentation by CBD-Intel head of legal analysis, Pablo Cano Trilla ...CBD-Intel regulatory news in brief, 20th-26th March
Written by CBD-Intel || 26th March 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from the EU, France, Germany, the UK, the US, China and Thailand ...
FTC-targeted company remains defiant, sees administrative fine as a victory
Written by CBD-Intel || 26th March 2021 || Business briefing |
The CEO of one company targeted by the US Federal Trade Commission (FTC) in the first ever group of fines handed down by the government agency to CBD companies considers the event to be a David and Goliath...
Mixed feelings as UK industry sees pros and cons in FSA switch on novel foods
Written by CBD-Intel || 25th March 2021 || Business briefing |
Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding ...
Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?
Written by CBD-Intel || 25th March 2021 || Blog |
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that...
Podcast: what lies beyond North America’s legal cannabis market?
Written by CBD-Intel || 22nd March 2021 || Podcasts , Resources |
Podcasts editor Jon Bruford is joined by Anthony Traurig, CBD-Intel legal analyst and US specialist, to discuss the legal and regulatory concerns that hang over cannabis in the US and Canada and the economic impact of Covid-19 ...CBD-Intel regulatory news in brief, 13th-19th March
Written by CBD-Intel || 19th March 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from Belgium, France, Italy, Slovakia, the UK, Canada, the US and South Africa ...
PG/phytol research should come with a health warning – lab rats are not humans
Written by CBD-Intel || 19th March 2021 || Business briefing |
Any conclusion drawn from studies on rodents must be treated with caution if we want to know about effects on humans ...
Not now, but soon – new industry bodies prepare for Brazil opening up to hemp
Written by CBD-Intel || 18th March 2021 || Business briefing |
Brazil still faces a serious attitude problem when it comes to advancing regulations for hemp and CBD, according to the leaders of two recently launched industry associations in the country ...CBD-Intel regulatory news in brief, 6th-12th March
Written by CBD-Intel || 12th March 2021 || Alerts roundup |
This week's regulatory news in brief includes updates from Czech Republic, France, Greece, Switzerland, Canada, the UK, Mexico, the US, Costa Rica, China, Morocco and Taiwan ...
Pregnant mice study touches on FDA questions, but more research is needed
Written by CBD-Intel || 12th March 2021 || Business briefing |
The US Food and Drug Administration (FDA) has called for an exploration of the effects of CBD on certain vulnerable populations such as children and pregnant women as part of its consumer update ...
Will the FSA-validated novel food submission list reveal commercially sensitive information?
Written by CBD-Intel || 11th March 2021 || Blog |
There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient...
Anxiety in Northern Ireland, UK’s EU gateway, as novel food deadline looms
Written by CBD-Intel || 11th March 2021 || Regulatory briefing |
As the UK’s deadline for novel food applications looms, many firms are upbeat about the prospects for CBD businesses in Northern Ireland, but almost all those CBD-Intel spoke to expressed frustration at a lack of clarity ...
Armenia looks to hemp legalisation as part of a route out of national crisis
Written by CBD-Intel || 10th March 2021 || Regulatory briefing |
Crisis-hit Armenia intends to legalise and regulate the production of hemp as a part of a package of economic measures to alleviate issues arising from the military conflict with Azerbaijan over the Nagorno-Karabakh region ...